VivoSim Labs (VIVS) Revenue & Revenue Breakdown
VivoSim Labs Revenue Highlights
Latest Revenue (Y)
$109.00K
Latest Revenue (Q)
$24.00K
VivoSim Labs Revenue by Period
VivoSim Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $109.00K | -70.54% |
| 2023-03-31 | $370.00K | -75.33% |
| 2022-03-31 | $1.50M | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-03-31 | $2.20M | -28.96% |
| 2019-03-31 | $3.09M | -32.85% |
| 2018-03-31 | $4.60M | 8.82% |
| 2017-03-31 | $4.23M | 185.23% |
| 2016-03-31 | $1.48M | 159.72% |
| 2015-03-31 | $571.00K | 50.66% |
| 2014-03-31 | $379.00K | -68.34% |
| 2012-12-31 | $1.20M | 100.00% |
| 2011-06-30 | - | - |
VivoSim Labs generated $109.00K in revenue during NA 2023, up -70.54% compared to the previous quarter, and up 3.53% compared to the same period a year ago.
VivoSim Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $24.00K | -20.00% |
| 2024-09-30 | $30.00K | -23.08% |
| 2024-06-30 | $39.00K | 34.48% |
| 2024-03-31 | $29.00K | 480.00% |
| 2023-12-31 | $5.00K | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $75.00K | -53.70% |
| 2023-03-31 | $162.00K | 23.66% |
| 2022-12-31 | $131.00K | 70.13% |
| 2022-09-30 | $77.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $1.50M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $298.00K | -75.77% |
| 2019-09-30 | $1.23M | 84.13% |
| 2019-06-30 | $668.00K | -1.76% |
| 2019-03-31 | $680.00K | -12.71% |
| 2018-12-31 | $779.00K | -17.39% |
| 2018-09-30 | $943.00K | 36.87% |
| 2018-06-30 | $689.00K | -37.65% |
| 2018-03-31 | $1.10M | -4.16% |
| 2017-12-31 | $1.15M | -14.91% |
| 2017-09-30 | $1.35M | 36.87% |
| 2017-06-30 | $990.00K | 21.92% |
| 2017-03-31 | $812.00K | -29.45% |
| 2016-12-31 | $1.15M | -16.35% |
| 2016-09-30 | $1.38M | 54.43% |
| 2016-06-30 | $891.00K | 62.59% |
| 2016-03-31 | $548.00K | 67.07% |
| 2015-12-31 | $328.00K | 8.97% |
| 2015-09-30 | $301.00K | -1.63% |
| 2015-06-30 | $306.00K | 14.61% |
| 2015-03-31 | $267.00K | 72.26% |
| 2014-12-31 | $155.00K | 210.00% |
| 2014-09-30 | $50.00K | -49.49% |
| 2014-06-30 | $99.00K | -13.91% |
| 2014-03-31 | $115.00K | -14.81% |
| 2013-12-31 | $135.00K | 486.96% |
| 2013-09-30 | $23.00K | -78.30% |
| 2013-06-30 | $106.00K | -50.70% |
| 2013-03-31 | $215.00K | -38.36% |
| 2012-12-31 | $348.79K | -25.67% |
| 2012-09-30 | $469.24K | 81.19% |
| 2012-06-30 | $258.98K | 115.81% |
| 2012-03-31 | $120.00K | 100.00% |
| 2011-12-31 | - | -100.00% |
| 2011-09-30 | $1.68K | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-03-31 | - | - |
VivoSim Labs generated $24.00K in revenue during Q3 2024, up -20.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
VivoSim Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics | $2.00M | $875.00K |
| RADX | Radiopharm Theranostics | $299.23K | - |
| VIVS | VivoSim Labs | $109.00K | $24.00K |
| TCRT | Alaunos Therapeutics | $10.00K | - |
| XTLB | XTL Biopharmaceuticals | - | - |
| PLRZ | Polyrizon | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| PMCB | PharmaCyte Biotech | - | - |
| KTTA | Pasithea Therapeutics | - | - |